
Trius Antibiotic Torezolid to be Highlighted at ECCMID Meeting
SAN DIEGO, May 4, 2011 (GLOBE NEWSWIRE) — Trius Therapeutics, Inc. (Nasdaq:TSRX), announced today that the results of two studies of torezolid phosphate (TR-701) will be presented at the upcoming European Congress of Clinical Microbiology […]